MEK1/2 Inhibitors Unlock the Constrained Interferon Response in Macrophages Through IRF1 Signaling
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MEK1/2 Inhibitors Unlock the Constrained Interferon Response in Macrophages Through IRF1 Signaling
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-08-27
DOI
10.3389/fimmu.2019.02020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-373 facilitates HSV-1 replication through suppression of type I IFN response by targeting IRF1
- (2018) Yiting Xie et al. BIOMEDICINE & PHARMACOTHERAPY
- The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells
- (2018) Vaclav Janovec et al. Frontiers in Immunology
- TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
- (2018) Christopher B. Rodell et al. Nature Biomedical Engineering
- The MEK Inhibitors Trametinib and Cobimetinib Induce a Type I Interferon Response in Human Keratinocytes
- (2017) Daniela Lulli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice
- (2017) Peter H. Goff et al. JOURNAL OF VIROLOGY
- A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
- (2017) E J Cheadle et al. LEUKEMIA
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys
- (2016) Erica N. Borducchi et al. NATURE
- PI3Kγ is a molecular switch that controls immune suppression
- (2016) Megan M. Kaneda et al. NATURE
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- Expansion of the Gene Ontology knowledgebase and resources
- (2016) NUCLEIC ACIDS RESEARCH
- Innate immune memory and homeostasis may be conferred through crosstalk between the TLR3 and TLR7 pathways
- (2016) Bing Liu et al. Science Signaling
- Innate immune memory and homeostasis may be conferred through crosstalk between the TLR3 and TLR7 pathways
- (2016) Bing Liu et al. Science Signaling
- Innate Immune Pattern Recognition: A Cell Biological Perspective
- (2015) Sky W. Brubaker et al. Annual Review of Immunology
- Restoration of IRF1-dependent anticancer effects by MEK inhibition in human cancer cells
- (2015) Nader AbuSara et al. CANCER LETTERS
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- Cutting Edge: Synchronization of IRF1, JunB, and C/EBPβ Activities during TLR3–TLR7 Cross-Talk Orchestrates Timely Cytokine Synergy in the Proinflammatory Response
- (2015) Qian Liu et al. JOURNAL OF IMMUNOLOGY
- Interferon-Stimulated Genes: A Complex Web of Host Defenses
- (2014) William M. Schneider et al. Annual Review of Immunology
- Tumor Progression Locus 2 (Tpl2) Kinase Promotes Chemokine Receptor Expression and Macrophage Migration during Acute Inflammation
- (2014) Sean M. Rowley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- I B Kinase Targets Interferon Regulatory Factor 1 in Activated T Lymphocytes
- (2014) M. Sgarbanti et al. MOLECULAR AND CELLULAR BIOLOGY
- K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5
- (2014) Kuzhuvelil B Harikumar et al. NATURE IMMUNOLOGY
- The clinical development of MEK inhibitors
- (2014) Yujie Zhao et al. Nature Reviews Clinical Oncology
- STRING v10: protein–protein interaction networks, integrated over the tree of life
- (2014) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Oncogenic Ras inhibits IRF1 to promote viral oncolysis
- (2014) Y Komatsu et al. ONCOGENE
- CpG ODN Nanorings Induce IFN from Plasmacytoid Dendritic Cells and Demonstrate Potent Vaccine Adjuvant Activity
- (2014) B. Gungor et al. Science Translational Medicine
- The synergy in cytokine production through MyD88-TRIF pathways is co-ordinated with ERK phosphorylation in macrophages
- (2013) Rebecca Suet Ting Tan et al. IMMUNOLOGY AND CELL BIOLOGY
- Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
- (2013) E. J. Morris et al. Cancer Discovery
- Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells
- (2012) Barbara Drobits et al. JOURNAL OF CLINICAL INVESTIGATION
- Coordinate Regulation of TPL-2 and NF- B Signaling in Macrophages by NF- B1 p105
- (2012) H.-T. Yang et al. MOLECULAR AND CELLULAR BIOLOGY
- Suppression of IFN-Induced Transcription Underlies IFN Defects Generated by Activated Ras/MEK in Human Cancer Cells
- (2012) Sherri L. Christian et al. PLoS One
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Characterization of the cellular action of the MSK inhibitor SB-747651A
- (2011) Shaista Naqvi et al. BIOCHEMICAL JOURNAL
- Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression
- (2011) Marta López-Peláez et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Unc93B1 Restricts Systemic Lethal Inflammation by Orchestrating Toll-like Receptor 7 and 9 Trafficking
- (2011) Ryutaro Fukui et al. IMMUNITY
- NF- B1 Inhibits TLR-Induced IFN- Production in Macrophages through TPL-2-Dependent ERK Activation
- (2011) H.-T. Yang et al. JOURNAL OF IMMUNOLOGY
- Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling
- (2011) Felix Geeraedts et al. PLoS Pathogens
- The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system
- (2011) Abbi L Engel et al. Expert Review of Clinical Pharmacology
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- IκBβ acts to inhibit and activate gene expression during the inflammatory response
- (2010) Ping Rao et al. NATURE
- Regulation of Adaptive Immunity by the Innate Immune System
- (2010) A. Iwasaki et al. SCIENCE
- TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells
- (2009) Frank Kaiser et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses
- (2009) S. Joshi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers
- (2008) Alex A. Adjei et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now